Skip to content
Subscriber Only

Purdue Challenged Over Attempt to Pay $38 Million in Bonuses

 Purdue Pharma OxyContin

 Purdue Pharma OxyContin

Photographer: George Frey/Bloomberg

Updated on

Purdue Pharma LP’s push to pay executives $38 million while it’s in bankruptcy was challenged by two dozen states, as the Connecticut attorney general called it “morally repugnant.”

The states on Thursday joined an objection filed earlier by the U.S. trustee assigned to the case. That filing argued that Purdue and its billionaire owners, the Sackler family, failed to give enough detail to justify the payments, including whether any of the recipients engaged in misconduct tied to marketing of the addictive painkiller OxyContin.